According to this latest study, the 2020 growth of Transforming Growth Factor Beta 1 will have significant change from previous year. By the most conservative estimates of global Transforming Growth Factor Beta 1 market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 1280.3 million in 2019. Over the next five years the Transforming Growth Factor Beta 1 market will register a 11.5% CAGR in terms of revenue, the global market size will reach US$ 1980 million by 2025.
This report presents a comprehensive overview, market shares, and growth opportunities of Transforming Growth Factor Beta 1 market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Pirfenidone
Galunisertib
Others
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
IPF
Cancer
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Roche
Shionogi Ltd
Acceleron Pharma Inc
Genzyme Corp
Isarna Therapeutics GmbH
Scholar Rock
Sirnaomics Inc
Eli Lilly and Co
Formation Biologics Inc
Novartis AG
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Transforming Growth Factor Beta 1 Consumption 2016-2026
2.1.2 Transforming Growth Factor Beta 1 Consumption CAGR by Region
2.2 Transforming Growth Factor Beta 1 Segment by Type
2.2.1 Pirfenidone
2.2.2 Galunisertib
2.2.3 Others
2.3 Transforming Growth Factor Beta 1 Sales by Type
2.3.1 Global Transforming Growth Factor Beta 1 Sales Market Share by Type (2016-2021)
2.3.2 Global Transforming Growth Factor Beta 1 Revenue and Market Share by Type (2016-2021)
2.3.3 Global Transforming Growth Factor Beta 1 Sale Price by Type (2016-2021)
2.4 Transforming Growth Factor Beta 1 Segment by Application
2.4.1 IPF
2.4.2 Cancer
2.4.3 Others
2.5 Transforming Growth Factor Beta 1 Sales by Application
2.5.1 Global Transforming Growth Factor Beta 1 Sale Market Share by Application (2016-2021)
2.5.2 Global Transforming Growth Factor Beta 1 Revenue and Market Share by Application (2016-2021)
2.5.3 Global Transforming Growth Factor Beta 1 Sale Price by Application (2016-2021)
3 Global Transforming Growth Factor Beta 1 by Company
3.1 Global Transforming Growth Factor Beta 1 Sales Market Share by Company
3.1.1 Global Transforming Growth Factor Beta 1 Sales by Company (2019-2021)
3.1.2 Global Transforming Growth Factor Beta 1 Sales Market Share by Company (2019-2021)
3.2 Global Transforming Growth Factor Beta 1 Revenue Market Share by Company
3.2.1 Global Transforming Growth Factor Beta 1 Revenue by Company (2019-2021)
3.2.2 Global Transforming Growth Factor Beta 1 Revenue Market Share by Company (2019-2021)
3.3 Global Transforming Growth Factor Beta 1 Sale Price by Company
3.4 Global Manufacturers Transforming Growth Factor Beta 1 Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Transforming Growth Factor Beta 1 Product Location Distribution
3.4.2 Players Transforming Growth Factor Beta 1 Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Transforming Growth Factor Beta 1 by Region
4.1 Global Transforming Growth Factor Beta 1 by Region
4.1.1 Global Transforming Growth Factor Beta 1 Sales by Region
4.1.2 Global Transforming Growth Factor Beta 1 Revenue by Region
4.2 Americas Transforming Growth Factor Beta 1 Sales Growth
4.3 APAC Transforming Growth Factor Beta 1 Sales Growth
4.4 Europe Transforming Growth Factor Beta 1 Sales Growth
4.5 Middle East & Africa Transforming Growth Factor Beta 1 Sales Growth
5 Americas
5.1 Americas Transforming Growth Factor Beta 1 Sales by Country
5.1.1 Americas Transforming Growth Factor Beta 1 Sales by Country (2016-2021)
5.1.2 Americas Transforming Growth Factor Beta 1 Revenue by Country (2016-2021)
5.2 Americas Transforming Growth Factor Beta 1 Sales by Type
5.3 Americas Transforming Growth Factor Beta 1 Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Transforming Growth Factor Beta 1 Sales by Region
6.1.1 APAC Transforming Growth Factor Beta 1 Sales by Region (2016-2021)
6.1.2 APAC Transforming Growth Factor Beta 1 Revenue by Region (2016-2021)
6.2 APAC Transforming Growth Factor Beta 1 Sales by Type
6.3 APAC Transforming Growth Factor Beta 1 Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Transforming Growth Factor Beta 1 by Country
7.1.1 Europe Transforming Growth Factor Beta 1 Sales by Country (2016-2021)
7.1.2 Europe Transforming Growth Factor Beta 1 Revenue by Country (2016-2021)
7.2 Europe Transforming Growth Factor Beta 1 Sales by Type
7.3 Europe Transforming Growth Factor Beta 1 Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Transforming Growth Factor Beta 1 by Country
8.1.1 Middle East & Africa Transforming Growth Factor Beta 1 Sales by Country (2016-2021)
8.1.2 Middle East & Africa Transforming Growth Factor Beta 1 Revenue by Country (2016-2021)
8.2 Middle East & Africa Transforming Growth Factor Beta 1 Sales by Type
8.3 Middle East & Africa Transforming Growth Factor Beta 1 Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Transforming Growth Factor Beta 1 Distributors
10.3 Transforming Growth Factor Beta 1 Customer
11 Global Transforming Growth Factor Beta 1 Market Forecast
11.1 Global Transforming Growth Factor Beta 1 Forecast by Region
11.1.1 Global Transforming Growth Factor Beta 1 Forecast by Regions (2021-2026)
11.2.2 Global Transforming Growth Factor Beta 1 Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Countries
11.3 APAC Forecast by Region
11.4 Europe Forecast by Countries
11.5 Middle East & Africa Forecast by Countries
11.6 Global Transforming Growth Factor Beta 1 Forecast by Type
11.7 Global Transforming Growth Factor Beta 1 Forecast by Application
12 Key Players Analysis
12.1 Roche
12.1.1 Roche Roche Company Information
12.1.2 Roche Transforming Growth Factor Beta 1 Product Offered
12.1.3 Roche Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Roche Main Business Overview
12.1.5 Roche Latest Developments
12.2 Shionogi Ltd
12.2.1 Shionogi Ltd Company Information
12.2.2 Shionogi Ltd Transforming Growth Factor Beta 1 Product Offered
12.2.3 Shionogi Ltd Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Shionogi Ltd Main Business Overview
12.2.5 Shionogi Ltd Latest Developments
12.3 Acceleron Pharma Inc
12.3.1 Acceleron Pharma Inc Company Information
12.3.2 Acceleron Pharma Inc Transforming Growth Factor Beta 1 Product Offered
12.3.3 Acceleron Pharma Inc Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Acceleron Pharma Inc Main Business Overview
12.3.5 Acceleron Pharma Inc Latest Developments
12.4 Genzyme Corp
12.4.1 Genzyme Corp Company Information
12.4.2 Genzyme Corp Transforming Growth Factor Beta 1 Product Offered
12.4.3 Genzyme Corp Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Genzyme Corp Main Business Overview
12.4.5 Genzyme Corp Latest Developments
12.5 Isarna Therapeutics GmbH
12.5.1 Isarna Therapeutics GmbH Company Information
12.5.2 Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Product Offered
12.5.3 Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Isarna Therapeutics GmbH Main Business Overview
12.5.5 Isarna Therapeutics GmbH Latest Developments
12.6 Scholar Rock
12.6.1 Scholar Rock Company Information
12.6.2 Scholar Rock Transforming Growth Factor Beta 1 Product Offered
12.6.3 Scholar Rock Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Scholar Rock Main Business Overview
12.6.5 Scholar Rock Latest Developments
12.7 Sirnaomics Inc
12.7.1 Sirnaomics Inc Company Information
12.7.2 Sirnaomics Inc Transforming Growth Factor Beta 1 Product Offered
12.7.3 Sirnaomics Inc Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Sirnaomics Inc Main Business Overview
12.7.5 Sirnaomics Inc Latest Developments
12.8 Eli Lilly and Co
12.8.1 Eli Lilly and Co Company Information
12.8.2 Eli Lilly and Co Transforming Growth Factor Beta 1 Product Offered
12.8.3 Eli Lilly and Co Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Eli Lilly and Co Main Business Overview
12.8.5 Eli Lilly and Co Latest Developments
12.9 Formation Biologics Inc
12.9.1 Formation Biologics Inc Company Information
12.9.2 Formation Biologics Inc Transforming Growth Factor Beta 1 Product Offered
12.9.3 Formation Biologics Inc Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Formation Biologics Inc Main Business Overview
12.9.5 Formation Biologics Inc Latest Developments
12.10 Novartis AG
12.10.1 Novartis AG Company Information
12.10.2 Novartis AG Transforming Growth Factor Beta 1 Product Offered
12.10.3 Novartis AG Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Novartis AG Main Business Overview
12.10.5 Novartis AG Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Transforming Growth Factor Beta 1 Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Pirfenidone
Table 3. Major Players of Galunisertib
Table 4. Major Players of Others
Table 5. Global Transforming Growth Factor Beta 1 Sales by Type (2016-2021) & (K Units)
Table 6. Global Transforming Growth Factor Beta 1 Sales Market Share by Type (2016-2021)
Table 7. Global Transforming Growth Factor Beta 1 Revenue by Type (2016-2021) & ($ million)
Table 8. Global Transforming Growth Factor Beta 1 Revenue Market Share by Type (2016-2021)
Table 9. Global Transforming Growth Factor Beta 1 Sale Price by Type (2016-2021)
Table 10. Global Transforming Growth Factor Beta 1 Sales by Application (2016-2021) & (K Units)
Table 11. Global Transforming Growth Factor Beta 1 Sales Market Share by Application (2016-2021)
Table 12. Global Transforming Growth Factor Beta 1 Value by Application (2016-2021)
Table 13. Global Transforming Growth Factor Beta 1 Revenue Market Share by Application (2016-2021)
Table 14. Global Transforming Growth Factor Beta 1 Sale Price by Application (2016-2021)
Table 15. Global Transforming Growth Factor Beta 1 Sales by Company (2019-2021) & (K Units)
Table 16. Global Transforming Growth Factor Beta 1 Sales Market Share by Company (2019-2021)
Table 17. Global Transforming Growth Factor Beta 1 Revenue by Company (2019-2021) ($ Millions)
Table 18. Global Transforming Growth Factor Beta 1 Revenue Market Share by Company (2019-2021)
Table 19. Global Transforming Growth Factor Beta 1 Sale Price by Company (2019-2021)
Table 20. Key Manufacturers Transforming Growth Factor Beta 1 Producing Area Distribution and Sales Area
Table 21. Players Transforming Growth Factor Beta 1 Products Offered
Table 22. Transforming Growth Factor Beta 1 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Transforming Growth Factor Beta 1 Sales by Region (2016-2021) (K Units)
Table 26. Global Transforming Growth Factor Beta 1 Sales Market Share by Region (2016-2021)
Table 27. Global Transforming Growth Factor Beta 1 Revenue by Region (2016-2021) & ($ Millions)
Table 28. Global Transforming Growth Factor Beta 1 Revenue Market Share by Region (2016-2021)
Table 29. Americas Transforming Growth Factor Beta 1 Sales by Country (2016-2021) & (K Units)
Table 30. Americas Transforming Growth Factor Beta 1 Sales Market Share by Country (2016-2021)
Table 31. Americas Transforming Growth Factor Beta 1 Revenue by Country (2016-2021) & ($ Millions)
Table 32. Americas Transforming Growth Factor Beta 1 Revenue Market Share by Country (2016-2021)
Table 33. Americas Transforming Growth Factor Beta 1 Sales by Type (2016-2021) & (K Units)
Table 34. Americas Transforming Growth Factor Beta 1 Sales Market Share by Type (2016-2021)
Table 35. Americas Transforming Growth Factor Beta 1 Sales by Application (2016-2021) & (K Units)
Table 36. Americas Transforming Growth Factor Beta 1 Sales Market Share by Application (2016-2021)
Table 37. APAC Transforming Growth Factor Beta 1 Sales by Region (2016-2021) & (K Units)
Table 38. APAC Transforming Growth Factor Beta 1 Sales Market Share by Region (2016-2021)
Table 39. APAC Transforming Growth Factor Beta 1 Revenue by Region (2016-2021) & ($ Millions)
Table 40. APAC Transforming Growth Factor Beta 1 Revenue Market Share by Region (2016-2021)
Table 41. APAC Transforming Growth Factor Beta 1 Sales by Type (2016-2021) & (K Units)
Table 42. APAC Transforming Growth Factor Beta 1 Sales Market Share by Type (2016-2021)
Table 43. APAC Transforming Growth Factor Beta 1 Sales by Application (2016-2021) & (K Units)
Table 44. APAC Transforming Growth Factor Beta 1 Sales Market Share by Application (2016-2021)
Table 45. Europe Transforming Growth Factor Beta 1 Sales by Country (2016-2021) & (K Units)
Table 46. Europe Transforming Growth Factor Beta 1 Sales Market Share by Country (2016-2021)
Table 47. Europe Transforming Growth Factor Beta 1 Revenue by Country (2016-2021) & ($ Millions)
Table 48. Europe Transforming Growth Factor Beta 1 Revenue Market Share by Country (2016-2021)
Table 49. Europe Transforming Growth Factor Beta 1 Sales by Type (2016-2021) & (K Units)
Table 50. Europe Transforming Growth Factor Beta 1 Sales Market Share by Type (2016-2021)
Table 51. Europe Transforming Growth Factor Beta 1 Sales by Application (2016-2021) & (K Units)
Table 52. Europe Transforming Growth Factor Beta 1 Sales Market Share by Application (2016-2021)
Table 53. Middle East & Africa Transforming Growth Factor Beta 1 Sales by Country (2016-2021) & (K Units)
Table 54. Middle East & Africa Transforming Growth Factor Beta 1 Sales Market Share by Country (2016-2021)
Table 55. Middle East & Africa Transforming Growth Factor Beta 1 Revenue by Country (2016-2021) & ($ Millions)
Table 56. Middle East & Africa Transforming Growth Factor Beta 1 Revenue Market Share by Country (2016-2021)
Table 57. Middle East & Africa Transforming Growth Factor Beta 1 Sales by Type (2016-2021) & (K Units)
Table 58. Middle East & Africa Transforming Growth Factor Beta 1 Sales Market Share by Type (2016-2021)
Table 59. Middle East & Africa Transforming Growth Factor Beta 1 Sales by Application (2016-2021) & (K Units)
Table 60. Middle East & Africa Transforming Growth Factor Beta 1 Sales Market Share by Application (2016-2021)
Table 61. Global Transforming Growth Factor Beta 1 Sales Forecast by Type (2021-2026) & (K Units)
Table 62. Global Transforming Growth Factor Beta 1 Sales Market Share Forecast by Type (2021-2026)
Table 63. Global Transforming Growth Factor Beta 1 Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 64. Global Transforming Growth Factor Beta 1 Revenue Market Share Forecast by Type (2021-2026)
Table 65. Global Transforming Growth Factor Beta 1 Sales Forecast by Application (2021-2026) & (K Units)
Table 66. Global Transforming Growth Factor Beta 1 Sales Market Share Forecast by Application (2021-2026)
Table 67. Global Transforming Growth Factor Beta 1 Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 68. Global Transforming Growth Factor Beta 1 Revenue Market Share Forecast by Application (2021-2026)
Table 69. Roche Basic Information, Transforming Growth Factor Beta 1 Manufacturing Base, Sales Area and Its Competitors
Table 70. Roche Transforming Growth Factor Beta 1 Product Offered
Table 71. Roche Transforming Growth Factor Beta 1 Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 72. Roche Main Business
Table 73. Roche Latest Developments
Table 74. Shionogi Ltd Basic Information, Transforming Growth Factor Beta 1 Manufacturing Base, Sales Area and Its Competitors
Table 75. Shionogi Ltd Transforming Growth Factor Beta 1 Product Offered
Table 76. Shionogi Ltd Transforming Growth Factor Beta 1 Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 77. Shionogi Ltd Main Business
Table 78. Shionogi Ltd Latest Developments
Table 79. Acceleron Pharma Inc Basic Information, Transforming Growth Factor Beta 1 Manufacturing Base, Sales Area and Its Competitors
Table 80. Acceleron Pharma Inc Transforming Growth Factor Beta 1 Product Offered
Table 81. Acceleron Pharma Inc Transforming Growth Factor Beta 1 Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 82. Acceleron Pharma Inc Main Business
Table 83. Acceleron Pharma Inc Latest Developments
Table 84. Genzyme Corp Basic Information, Transforming Growth Factor Beta 1 Manufacturing Base, Sales Area and Its Competitors
Table 85. Genzyme Corp Transforming Growth Factor Beta 1 Product Offered
Table 86. Genzyme Corp Transforming Growth Factor Beta 1 Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 87. Genzyme Corp Main Business
Table 88. Genzyme Corp Latest Developments
Table 89. Isarna Therapeutics GmbH Basic Information, Transforming Growth Factor Beta 1 Manufacturing Base, Sales Area and Its Competitors
Table 90. Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Product Offered
Table 91. Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 92. Isarna Therapeutics GmbH Main Business
Table 93. Isarna Therapeutics GmbH Latest Developments
Table 94. Scholar Rock Basic Information, Transforming Growth Factor Beta 1 Manufacturing Base, Sales Area and Its Competitors
Table 95. Scholar Rock Transforming Growth Factor Beta 1 Product Offered
Table 96. Scholar Rock Transforming Growth Factor Beta 1 Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 97. Scholar Rock Main Business
Table 98. Scholar Rock Latest Developments
Table 99. Sirnaomics Inc Basic Information, Transforming Growth Factor Beta 1 Manufacturing Base, Sales Area and Its Competitors
Table 100. Sirnaomics Inc Transforming Growth Factor Beta 1 Product Offered
Table 101. Sirnaomics Inc Transforming Growth Factor Beta 1 Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 102. Sirnaomics Inc Main Business
Table 103. Sirnaomics Inc Latest Developments
Table 104. Eli Lilly and Co Basic Information, Transforming Growth Factor Beta 1 Manufacturing Base, Sales Area and Its Competitors
Table 105. Eli Lilly and Co Transforming Growth Factor Beta 1 Product Offered
Table 106. Eli Lilly and Co Transforming Growth Factor Beta 1 Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 107. Eli Lilly and Co Main Business
Table 108. Eli Lilly and Co Latest Developments
Table 109. Formation Biologics Inc Basic Information, Transforming Growth Factor Beta 1 Manufacturing Base, Sales Area and Its Competitors
Table 110. Formation Biologics Inc Transforming Growth Factor Beta 1 Product Offered
Table 111. Formation Biologics Inc Transforming Growth Factor Beta 1 Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 112. Formation Biologics Inc Main Business
Table 113. Formation Biologics Inc Latest Developments
Table 114. Novartis AG Basic Information, Transforming Growth Factor Beta 1 Manufacturing Base, Sales Area and Its Competitors
Table 115. Novartis AG Transforming Growth Factor Beta 1 Product Offered
Table 116. Novartis AG Transforming Growth Factor Beta 1 Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 117. Novartis AG Main Business
Table 118. Novartis AG Latest Developments
List of Figures
Figure 1. Picture of Transforming Growth Factor Beta 1
Figure 2. Transforming Growth Factor Beta 1 Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Transforming Growth Factor Beta 1 Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global Transforming Growth Factor Beta 1 Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Transforming Growth Factor Beta 1 Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Pirfenidone
Figure 10. Product Picture of Galunisertib
Figure 11. Product Picture of Others
Figure 12. Global Transforming Growth Factor Beta 1 Sales Market Share by Type in 2020
Figure 13. Global Transforming Growth Factor Beta 1 Revenue Market Share by Type (2016-2021)
Figure 14. Transforming Growth Factor Beta 1 Consumed in IPF
Figure 15. Global Transforming Growth Factor Beta 1 Market: IPF (2016-2021) & (K Units)
Figure 16. Transforming Growth Factor Beta 1 Consumed in Cancer
Figure 17. Global Transforming Growth Factor Beta 1 Market: Cancer (2016-2021) & (K Units)
Figure 18. Transforming Growth Factor Beta 1 Consumed in Others
Figure 19. Global Transforming Growth Factor Beta 1 Market: Others (2016-2021) & (K Units)
Figure 20. Global Transforming Growth Factor Beta 1 Sales Market Share by Application (2016-2021)
Figure 21. Global Transforming Growth Factor Beta 1 Revenue Market Share by Application in 2020
Figure 22. Global Transforming Growth Factor Beta 1 Revenue Market by Company in 2020 ($ Million)
Figure 23. Global Transforming Growth Factor Beta 1 Revenue Market Share by Company in 2020
Figure 24. Global Transforming Growth Factor Beta 1 Sales Market Share by Regions (2016-2021)
Figure 25. Global Transforming Growth Factor Beta 1 Revenue Market Share by Region in 2020
Figure 26. Americas Transforming Growth Factor Beta 1 Sales 2016-2021 (K Units)
Figure 27. Americas Transforming Growth Factor Beta 1 Revenue 2016-2021 ($ Millions)
Figure 28. APAC Transforming Growth Factor Beta 1 Sales 2016-2021 (K Units)
Figure 29. APAC Transforming Growth Factor Beta 1 Revenue 2016-2021 ($ Millions)
Figure 30. Europe Transforming Growth Factor Beta 1 Sales 2016-2021 (K Units)
Figure 31. Europe Transforming Growth Factor Beta 1 Revenue 2016-2021 ($ Millions)
Figure 32. Middle East & Africa Transforming Growth Factor Beta 1 Sales 2016-2021 (K Units)
Figure 33. Middle East & Africa Transforming Growth Factor Beta 1 Revenue 2016-2021 ($ Millions)
Figure 34. Americas Transforming Growth Factor Beta 1 Sales Market Share by Country in 2020
Figure 35. Americas Transforming Growth Factor Beta 1 Revenue Market Share by Country in 2020
Figure 36. Americas Transforming Growth Factor Beta 1 Sales Market Share by Type in 2020
Figure 37. Americas Transforming Growth Factor Beta 1 Sales Market Share by Application in 2020
Figure 38. United States Transforming Growth Factor Beta 1 Revenue Growth 2016-2021 ($ Millions)
Figure 39. Canada Transforming Growth Factor Beta 1 Revenue Growth 2016-2021 ($ Millions)
Figure 40. Mexico Transforming Growth Factor Beta 1 Revenue Growth 2016-2021 ($ Millions)
Figure 41. Brazil Transforming Growth Factor Beta 1 Revenue Growth 2016-2021 ($ Millions)
Figure 42. APAC Transforming Growth Factor Beta 1 Sales Market Share by Region in 2020
Figure 43. APAC Transforming Growth Factor Beta 1 Revenue Market Share by Regions in 2020
Figure 44. APAC Transforming Growth Factor Beta 1 Sales Market Share by Type in 2020
Figure 45. APAC Transforming Growth Factor Beta 1 Sales Market Share by Application in 2020
Figure 46. China Transforming Growth Factor Beta 1 Revenue Growth 2016-2021 ($ Millions)
Figure 47. Japan Transforming Growth Factor Beta 1 Revenue Growth 2016-2021 ($ Millions)
Figure 48. Korea Transforming Growth Factor Beta 1 Revenue Growth 2016-2021 ($ Millions)
Figure 49. Southeast Asia Transforming Growth Factor Beta 1 Revenue Growth 2016-2021 ($ Millions)
Figure 50. India Transforming Growth Factor Beta 1 Revenue Growth 2016-2021 ($ Millions)
Figure 51. Australia Transforming Growth Factor Beta 1 Revenue Growth 2016-2021 ($ Millions)
Figure 52. Europe Transforming Growth Factor Beta 1 Sales Market Share by Country in 2020
Figure 53. Europe Transforming Growth Factor Beta 1 Revenue Market Share by Country in 2020
Figure 54. Europe Transforming Growth Factor Beta 1 Sales Market Share by Type in 2020
Figure 55. Europe Transforming Growth Factor Beta 1 Sales Market Share by Application in 2020
Figure 56. Germany Transforming Growth Factor Beta 1 Revenue Growth 2016-2021 ($ Millions)
Figure 57. France Transforming Growth Factor Beta 1 Revenue Growth 2016-2021 ($ Millions)
Figure 58. UK Transforming Growth Factor Beta 1 Revenue Growth 2016-2021 ($ Millions)
Figure 59. Italy Transforming Growth Factor Beta 1 Revenue Growth 2016-2021 ($ Millions)
Figure 60. Russia Transforming Growth Factor Beta 1 Revenue Growth 2016-2021 ($ Millions)
Figure 61. Middle East & Africa Transforming Growth Factor Beta 1 Sales Market Share by Country in 2020
Figure 62. Middle East & Africa Transforming Growth Factor Beta 1 Revenue Market Share by Country in 2020
Figure 63. Middle East & Africa Transforming Growth Factor Beta 1 Sales Market Share by Type in 2020
Figure 64. Middle East & Africa Transforming Growth Factor Beta 1 Sales Market Share by Application in 2020
Figure 65. Egypt Transforming Growth Factor Beta 1 Revenue Growth 2016-2021 ($ Millions)
Figure 66. South Africa Transforming Growth Factor Beta 1 Revenue Growth 2016-2021 ($ Millions)
Figure 67. Israel Transforming Growth Factor Beta 1 Revenue Growth 2016-2021 ($ Millions)
Figure 68. Turkey Transforming Growth Factor Beta 1 Revenue Growth 2016-2021 ($ Millions)
Figure 69. GCC Country Transforming Growth Factor Beta 1 Revenue Growth 2016-2021 ($ Millions)
Figure 70. Channels of Distribution
Figure 71. Distributors Profiles